MAPK14 and prostate carcinoma: The measurement of the intensity of the immunohistochemical reaction using computer image analysis, confirmed by statistical evaluation, revealed lower immunoreactivity of ERK1/2, p38, β‐catenin, and E‐cadherin in prostate cancer compared to BPH (epithelium and stroma).